About
Sleep Apnea Drugs
Areas of Focus
Categories
Small Molecule PharmaceuticalBoston & New England
Clinical Trials (19)
View allTotal Trials
19
As Lead Sponsor
13
As Collaborator
6
Total Enrollment
3,476
By Phase
NA: 1PHASE3: 3PHASE2: 12PHASE1/PHASE2: 2PHASE2/PHASE3: 1
By Status
COMPLETED: 17ACTIVE_NOT_RECRUITING: 1ENROLLING_BY_INVITATION: 1
Clinical Trials Pipeline19 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
Today
Hover over trial bars to see details
Recent Trials
NCT06525337Collaborator
Adherence to Health Coaching with Wearable Devices: Enhancing Patient Engagement and Outcomes
NAActive, not recruiting
60 participants
Started: Aug 30, 2024 · Completed: Mar 30, 2025
NCT06566820Lead Sponsor
Continuation Protocol for Obstructive Sleep Apnea (OSA)
PHASE3Enrolling by invitation
1,280 participants
Started: Jul 3, 2024 · Completed: Jun 30, 2026
NCT06400615Lead Sponsor
Study That Tests AD109 in Patients Taking GLP-1 Drugs
PHASE2Completed
40 participants
Started: May 20, 2024 · Completed: Dec 26, 2024
NCT05813275Lead Sponsor
Parallel-Arm Study to Compare AD109 to Placebo With Patients With OSA (SynAIRgy Study)
PHASE3Completed
646 participants
Started: Sep 16, 2023 · Completed: Mar 14, 2025
NCT05811247Lead Sponsor
Parallel Arm Trial of AD109 and Placebo With Patients With OSA (LunAIRo)
PHASE3Completed
660 participants
Started: Aug 28, 2023 · Completed: May 7, 2025
Locations (1)
Headquarters
Cambridge, MA, United States
Map
Loading map...